JPH02110113A - ポリスチレン−ジビニベンゼル共重合体 - Google Patents

ポリスチレン−ジビニベンゼル共重合体

Info

Publication number
JPH02110113A
JPH02110113A JP63120403A JP12040388A JPH02110113A JP H02110113 A JPH02110113 A JP H02110113A JP 63120403 A JP63120403 A JP 63120403A JP 12040388 A JP12040388 A JP 12040388A JP H02110113 A JPH02110113 A JP H02110113A
Authority
JP
Japan
Prior art keywords
compound
polystyrene
group
quaternary ammonium
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63120403A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0515987B2 (enExample
Inventor
Robert E O'brien
ロバート・イー・オブライエン
Nathan Robert Tzodikov
ネイザン・ロバート・ツォディコフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/105,272 external-priority patent/US4358434A/en
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of JPH02110113A publication Critical patent/JPH02110113A/ja
Publication of JPH0515987B2 publication Critical patent/JPH0515987B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP63120403A 1979-12-19 1988-05-17 ポリスチレン−ジビニベンゼル共重合体 Granted JPH02110113A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/105,272 US4358434A (en) 1979-12-19 1979-12-19 Method, composition and kit for stabilizing radiolabeled compounds
US178609 1980-08-15
US06/178,609 US4390517A (en) 1979-12-19 1980-08-15 Method, composition and kit for stabilizing radiolabeled compounds
US105272 1993-08-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP18026980A Division JPS5697871A (en) 1979-12-19 1980-12-19 Method* composition* and tool assembly for stabilization of radioactive marking compound

Publications (2)

Publication Number Publication Date
JPH02110113A true JPH02110113A (ja) 1990-04-23
JPH0515987B2 JPH0515987B2 (enExample) 1993-03-03

Family

ID=26802419

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63120403A Granted JPH02110113A (ja) 1979-12-19 1988-05-17 ポリスチレン−ジビニベンゼル共重合体

Country Status (5)

Country Link
US (1) US4390517A (enExample)
EP (1) EP0031121B1 (enExample)
JP (1) JPH02110113A (enExample)
CA (1) CA1198365A (enExample)
DE (1) DE3070719D1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
DE3331159A1 (de) * 1983-08-30 1985-03-14 Hoechst Ag, 6230 Frankfurt N-(4-aminobenzoyl)-aminodicarbonsaeuren zur stabilisierung von technetium-99m-praeparaten, stabilisierte injektionspraeparate und verfahren zu ihrer herstellung
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
EP0513510A1 (en) * 1991-05-01 1992-11-19 E.R. SQUIBB & SONS, INC. Method for stabilizing radiolabeled biological molecules using ion exchange resins
CA2105402C (en) * 1992-04-30 2000-04-04 Roger M. Price Radiolabelled compound formulations
US5686058A (en) * 1992-04-30 1997-11-11 Amersham International Plc Radiolabelled nucleotide formulations stored in an unfrozen state
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
FR2727687B1 (fr) * 1994-12-02 1997-01-24 Isotopchim Sarl Stabilisation de composes radiomarques
WO1997001520A1 (en) * 1995-06-28 1997-01-16 E.I. Du Pont De Nemours And Company Composition and method for stabilizing radiolabeled organic compounds
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
FR2763505B1 (fr) * 1997-05-22 2000-10-06 Oreal Utilisation en cosmetique de certains polymeres polyamines comme agents anti-oxydants
AU2985100A (en) 1999-02-08 2000-08-25 Checkpoint Genetics, Inc. (n)-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
HUP0101921A2 (hu) * 2001-05-10 2004-01-28 Izotóp Intézet Kft Radioaktívan jelzett nukleotido/ka/t tartalmazó preparátumok és eljárás azok előállítására
JP4611017B2 (ja) * 2002-04-30 2011-01-12 エモリー ユニバーシティー 腫瘍画像化化合物
JP5139678B2 (ja) * 2003-07-24 2013-02-06 ブラッコ・イメージング・ソシエタ・ペル・アチオニ 安定な放射性医薬品組成物およびその製法
AU2006262502A1 (en) 2005-06-23 2007-01-04 Emory Univerisity Imaging agents
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
GB201007353D0 (en) 2010-04-30 2010-06-16 Algeta Asa Method
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD88780A (enExample) *
BE759895R (fr) * 1969-12-04 1971-06-04 Squibb & Sons Inc Appareil et procede pour determiner la fonction
SU432218A1 (ru) * 1972-11-14 1974-06-15 Способ извлечения и концентрирования цветных металлов
US3928293A (en) * 1974-04-01 1975-12-23 Dynapol Corp Polymeric reagent
US4029706A (en) * 1974-04-01 1977-06-14 Dynapol Reduction with polymeric reagent
SE420733B (sv) * 1974-05-30 1981-10-26 Exploaterings Ab Tbf Gelprodukt, innehallande tiosulfatgrupper samt sett for framstellning derav
US4048296A (en) * 1975-05-27 1977-09-13 Mallinckrodt, Inc. Radiopharmaceutical scanning agents
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4107867A (en) * 1975-10-16 1978-08-22 Kennedy Benton B Catfish trap
US4107284A (en) * 1975-10-28 1978-08-15 Sultanian Ishkhan V Radioimmunoassay procedure using a stabilized complex
CA1083508A (fr) * 1975-11-13 1980-08-12 Jacques Grange Supports porteurs de chaines laterales, procedes d'obtention de ces supports, procedes de fixation de composes organiques comportant un residu glucidique sur lesdits supports, produits et reactifs resultant de ladite fixation chimique
US4115540A (en) * 1976-06-16 1978-09-19 The University Of Kentucky Research Foundation Radiodiagnostic agent
US4107283A (en) * 1976-07-19 1978-08-15 New England Nuclear Corporation Tracer for circulation determinations
US4112064A (en) * 1977-02-22 1978-09-05 Hoffmann-La Roche Inc. Stabilized angiotensin I solutions
JPS5489019A (en) * 1977-11-29 1979-07-14 Mochida Pharm Co Ltd Immunochemical measuring reagent
US4229427A (en) * 1978-06-28 1980-10-21 The Procter & Gamble Company Radioactive scanning agents with hydroquinone stabilizer

Also Published As

Publication number Publication date
EP0031121B1 (en) 1985-05-29
US4390517A (en) 1983-06-28
JPH0515987B2 (enExample) 1993-03-03
DE3070719D1 (en) 1985-07-04
EP0031121A1 (en) 1981-07-01
CA1198365A (en) 1985-12-24

Similar Documents

Publication Publication Date Title
JPH02110113A (ja) ポリスチレン−ジビニベンゼル共重合体
EP0038756B1 (en) Cationic lipophilic complexes of 99m tc useful for myocardial and hepatobiliary imaging
JPS645256B2 (enExample)
JPH0211105B2 (enExample)
PT89476A (pt) Processo para a preparacao de complexos quelato de metal a partir de um complexo de um composto beta-dicarbonilo e de iao metalico
CA3148952C (en) Method for synthesizing zirconium complex
US4793987A (en) Stabilized radiolabelled compounds
JP2025506322A5 (enExample)
US4885100A (en) Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes
WO2004001767A1 (en) Ion exchange materials for use in a bi-213 generator
CA1198549A (en) Stabilization of radiolabeled organic compound
US12606575B2 (en) Method for synthesizing zirconium complex
US20130041104A1 (en) Conjugates of 18f carriers having bioactive, organic compounds and the preparation thereof
US4028389A (en) Metallocenes and metallocene derivatives having a radioactive central atom
CN117500525A (zh) pH调节的抗坏血酸溶液的制备
JPS6280237A (ja) 水中のガリウムの濃縮分離方法
JP2009521469A (ja) 薬剤をα−粒子エミッターによって放射標識するための安定化組成物および方法
SUGIURA et al. Studies on the sulfur-containing chelating agents. XXXIII. Interaction of penicillamine and its related compounds with chromium ion and hemoglobin-bound chromium
US20070224115A1 (en) Polymeric chelators for radionuclide delivery systems
US5008418A (en) Tris(isonitrile)copper(I) adducts for preparing radionuclide complexes
JP3549115B2 (ja) テクネチウム−９９ｍで標識された臓器特異的物質の製造方法
Hojo et al. Specific Ability of Sulfur-Ligands on Removal of 203Hg-Labeled Organomercury from Hemoglobin in Comparison with Nitrogen-Ligands
US11279715B2 (en) Process for removing radioactive isotopes from aqueous fluids by fluorine containing reagents, fluorine containing, water-insoluble salts of the radioactive isotopes, and their use as therapeutic agents
Nakayama et al. Application of a macromolecular Sn (II) complex to the preparation of 99mTc radiopharmaceuticals
Janoki et al. Effect of carbodiimide as a coupling reagent on the metal binding properties of desferrioxamine: Model studies for the desferrioxamine—Human serum albumin conjugate